Steven M. Scott, MD, HS’74-78, has been named the recipient of the 2025 Distinguished Service Award by the Duke Medical Alumni Association in recognition of his selfless service, steadfast passion for Duke, and transformative contributions to education, college athletics and health care institutions.

Pamela S. Douglas, MD, has been named a recipient of a 2025 Distinguished Faculty Award by the Duke Medical Alumni Association in recognition of her pioneering contributions to the field of cardiology.

Lori J. Pierce, MD’85, has been named the recipient of a Distinguished Alumni Award by the Duke Medical Alumni Association in recognition of her pioneering work in advancing breast cancer treatment and her leadership in education and training.

Joseph Heitman, MD, PhD, has been named the recipient of a 2025 Distinguished Faculty Award by the Duke Medical Alumni Association in recognition of his significant contributions to biomedical science, education, clinical impact, and leadership.

Cameron R. Wolfe, MD, HS’07-’08, professor of medicine in the Division of Infectious Diseases at Duke University, has been named a recipient of a Duke Medical Alumni Association 2025 Distinguished Faculty Award in recognition of his sustained contributions to clinical care, research, education, and institutional leadership.

Amy P. Murtha, MD, HS’92-’98, has been honored with a 2025 Distinguished Alumni Award by the Duke Medical Alumni Association for her sustained commitment to improving maternal-fetal health and advancing academic medicine.

Technological advances such as artificial intelligence, big data, and gene editing have dramatically accelerated the pace of biomedical research and health care. It can be hard to predict what new developments will arise next week, much less in the next 10, 50, or 100 years.

Nicole Calakos, MD, PhD, is the Lincoln Financial Group Distinguished Professor of Neurobiology and specializes in synaptic physiology research and Parkinson’s disease and other movement disorders. She highlights the transformative impact of big data, AI, and cell modeling on neuroscience research, emphasizing the potential for advances in regenerative therapies and neural prostheses.

Dr. Aditee Narayan, a leader in medical education at Duke, spearheaded the Patient First curriculum, emphasizing modern, patient-centered care and interdisciplinary collaboration. She envisions future physicians as change agents, equipped with clinical skills and the ability to innovate and address health care disparities.

Dr. Kevin Saunders, a leader at the Duke Human Vaccine Institute, highlights the advancements in vaccine research, emphasizing the use of computational design, AI, and mRNA technology. Duke is at the forefront with significant progress in HIV, coronavirus, and cancer vaccines, and is developing pan-coronavirus and pan-influenza vaccines.